Avondale Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-250
Closed -$38.8K 130
2023
Q1
$38.8K Sell
250
-450
-64% -$72.7K 0.03% 88
2022
Q4
$124K Hold
700
0.11% 47
2022
Q3
$114K Buy
+700
New +$118K 0.12% 48
2022
Q2
Sell
-30
Closed -$5K 127
2022
Q1
$5K Buy
+30
New +$5.11K 0.01% 106
2018
Q2
Sell
-126
Closed -$16K 99
2018
Q1
$16K Hold
126
0.01% 71
2017
Q4
$18K Buy
+126
New +$17.6K 0.02% 73

Other funds holding JNJ

Avondale Wealth Management's JNJ Position: Q2 2023 in Review

Avondale Wealth Management sold out of Johnson & Johnson (JNJ) in Q2 2023, closing a stake of 250 shares — an estimated $38.8K sold.

Avondale Wealth Management first reported a position in JNJ in Q4 2017 and held it in 6 quarters. The position peaked at $124K in Q4 2022. 3,751 funds tracked by Wall St. Rank hold JNJ as of Q2 2023.

  • Avondale Wealth Management reported no remaining Johnson & Johnson position as of Q2 2023 after selling out during the quarter.
  • Avondale Wealth Management sold 250 Johnson & Johnson shares in Q2 2023, an estimated $38.8K.
  • Avondale Wealth Management first reported a position in Johnson & Johnson in Q4 2017 and held it in 6 quarters.
  • Avondale Wealth Management's Johnson & Johnson position peaked at $124K in Q4 2022.
  • 3,751 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2023.

Based on Avondale Wealth Management's 13F filing for Q2 2023, filed 6 Jul 2023.